Market cap
$290 Mln
Recently Viewed
Clear AllMarket cap
$290 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
29.6
P/B Ratio
1.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$29 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-194.1
Debt to Equity
0
Book Value
$--
EPS
$1.7
Face value
--
Shares outstanding
23,000,000
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SCP & Healthcare Acquisition Co (SHAC)
| 2.8 | 0.8 | 2.0 | 3.4 | -- | -- | -- |
|
BSE Sensex*
| -9.2 | 1.1 | -8.4 | 2.2 | 8.4 | 9.9 | 11.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
SCP & Healthcare Acquisition Co (SHAC)
|
10.1 | 289.7 | 0.0 | 10.1 | -- | 4.6 | 29.6 | 1.3 |
| 10.1 | 505.8 | -0.5 | 18.7 | -4,040.4 | 4.9 | 27.3 | 1.3 | |
| 10.1 | 433.4 | 0.0 | 7.1 | -- | -- | 71.8 | 1.3 | |
| 10.0 | 1,726.7 | 0.0 | 43.3 | -- | -- | 9.3 | 1.3 | |
| 10.1 | 434.3 | 0.0 | 9.6 | -- | -- | 45.8 | 1.3 | |
| 25.1 | 445.4 | 0.0 | 13.3 | -- | -- | 71.7 | 1.1 | |
| 10.0 | 580.1 | 0.0 | 6,291,149.5 | -- | -- | 28.7 | 1.1 | |
| 10.1 | 435.1 | 0.0 | 12.5 | -- | -- | 34.8 | 1.3 | |
| 10.0 | 581.1 | 0.0 | 9.5 | -- | -- | 71.6 | 1.3 | |
| 10.1 | 443.1 | 0.0 | -4.4 | -- | -- | 91.5 | 1.3 |
SCP & CO Healthcare Acquisition Company does not have significant business. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more... businesses. It intends to identify a prospective target business in the healthcare technology or healthcare-related platform in the United States and other developed countries. The company was incorporated in 2020 and is based in Tampa, Florida. Read more
CEO & Director
Mr. Scott N. Feuer
CEO & Director
Mr. Scott N. Feuer
Headquarters
Tampa, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of SCP & Healthcare Acquisition Co (SHAC) is $10.08 (NASDAQ) as of 16-Dec-2022 09:30 EDT. SCP & Healthcare Acquisition Co (SHAC) has given a return of 3.35% in the last 1 years.
The P/E ratio of SCP & Healthcare Acquisition Co (SHAC) is 29.64 times as on 13-Jan-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
6.71
|
0.28
|
|
2020
|
--
|
--
|
|
2021
|
6.71
|
0.28
|
|
2020
|
--
|
--
|
The 52-week high and low of SCP & Healthcare Acquisition Co (SHAC) are Rs -- and Rs -- as of 13-Apr-2026.
SCP & Healthcare Acquisition Co (SHAC) has a market capitalisation of $ 290 Mln as on 13-Jan-2023. As per SEBI classification, it is a Small Cap company.
Before investing in SCP & Healthcare Acquisition Co (SHAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.